AngioDynamics, Inc. (ANGO)
NASDAQ: ANGO · Real-Time Price · USD
10.83
-0.04 (-0.37%)
At close: Mar 6, 2026, 4:00 PM EST
10.80
-0.03 (-0.28%)
After-hours: Mar 6, 2026, 7:35 PM EST

AngioDynamics Revenue

AngioDynamics had revenue of $79.43M in the quarter ending November 30, 2025, with 9.04% growth. This brings the company's revenue in the last twelve months to $307.31M, up 7.26% year-over-year. In the fiscal year ending May 31, 2025, AngioDynamics had annual revenue of $292.50M, down -3.76%.

Revenue (ttm)
$307.31M
Revenue Growth
+7.26%
P/S Ratio
1.45
Revenue / Employee
$455,268
Employees
675
Market Cap
446.38M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
May 31, 2025292.50M-11.42M-3.76%
May 31, 2024303.91M-34.84M-10.28%
May 31, 2023338.75M22.53M7.13%
May 31, 2022316.22M25.21M8.66%
May 31, 2021291.01M26.85M10.17%
May 31, 2020 Pro Pro Pro
May 31, 2019 Pro Pro Pro
May 31, 2018 Pro Pro Pro
May 31, 2017 Pro Pro Pro
May 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Embecta 1.08B
Azenta 595.03M
STAAR Surgical Company 239.44M
OraSure Technologies 115.02M
Sanara MedTech 101.88M
BioLife Solutions 96.21M
KORU Medical Systems 39.07M
Utah Medical Products 38.52M
Revenue Rankings